Abstract
Laser tattoo removal often requires multiple treatment sessions despite advances in picosecond laser technology. Multimodal approaches aimed at improving treatment efficiency are increasingly being explored. This study retrospectively evaluated the clinical outcomes of a vacuum-assisted multimodal picosecond laser tattoo removal protocol. A retrospective observational case series was conducted including 16 tattoos that completed treatment with standardized photographic follow-up. The protocol combined fractional ablative laser pretreatment (1064 nm, 3–5 stacks), followed by two full-beam picosecond 1064 nm passes with application of a vacuum-assisted device between passes. Standardized images were acquired using the Quantificare imaging system. Treatment outcomes were independently evaluated by three blinded experts. Kirby–Desai estimated treatment sessions were additionally calculated as a historical comparative reference. Sixteen tattoos completed treatment and were included in the final analysis. Mean pigment clearance exceeded 90% following a mean of 3.19 treatment sessions, with high interobserver agreement among blinded evaluators. The observed number of treatment sessions was lower than Kirby–Desai estimated values used as historical reference. No severe long-term adverse events were observed. This retrospective case series suggests that a vacuum-assisted multimodal picosecond laser tattoo removal protocol may be associated with high tattoo clearance rates using relatively few treatment sessions. However, given the retrospective design, absence of a control group, and multimodal nature of the protocol, the independent contribution of vacuum assistance cannot be determined. Prospective controlled studies are needed to further evaluate the role of adjunctive mechanical approaches in tattoo removal optimization.
Keywords: Picosecond Laser, Tattoo Removal, Vacuum-Assisted Therapy, Multimodal Protocol, Laser Therapy
Introduction
Tattoos consist of the intradermal deposition of pigments that are subsequently phagocytosed by macrophages, fibroblasts, and mast cells, allowing them to remain stable within the dermis over long periods [1]. Despite their growing popularity, approximately 20% of tattooed individuals report some degree of regret, particularly in cases of visible tattoos, tattoos acquired at a young age, or in professional contexts where physical appearance is highly valued [2–4]. This trend parallels the expansion of the global tattoo removal market, which is projected to grow at an annual rate of 19.4% between 2023 and 2031 [5, 6].
Laser therapy is currently considered the gold standard for tattoo removal and is based on the principle of selective photothermolysis, in which ultrashort laser pulses fragment pigment particles while minimizing damage to surrounding tissues [7, 8]. Picosecond lasers represent an important technological advance over Q-switched nanosecond systems due to their stronger photomechanical effects and more efficient pigment fragmentation. Nevertheless, laser tattoo removal remains limited by the so-called “popcorn effect,” characterized by the formation of gas bubbles that act as an optical shield and reduce the effectiveness of subsequent laser passes [7, 9]. Several strategies have been proposed to overcome this limitation, including the R-20 protocol and the use of perfluorodecalin patches; however, these approaches may increase treatment time, cost, and procedural complexity [9, 10]. More recently, techniques such as microdrilling and FracTAT®, which combine fractional ablative laser pretreatment with subsequent full-beam laser passes, have demonstrated reductions in treatment time and number of sessions but do not completely eliminate the optical shielding phenomenon [7]. However, despite these advances, optimization of tattoo removal protocols remains an active area of research.
In addition to the physical fragmentation of pigment particles induced by laser energy, the long-term clearance of tattoo ink depends on biological processes involving macrophage phagocytosis and lymphatic transport of fragmented pigment particles. These processes play a critical role in the gradual fading of tattoos following laser treatment and may be influenced by local vascularization and tissue dynamics. Recent in vivo imaging studies using multiphoton tomography have demonstrated that fragmented tattoo particles may persist within epidermal and dermal layers for several weeks to months after picosecond laser treatment, supporting the concept of prolonged transepidermal and inflammatory-mediated pigment clearance [11]. Consequently, approaches that improve local perfusion, lymphatic drainage, or tissue mechanics may enhance the biological clearance phase following laser-induced pigment fragmentation.
Negative pressure therapy has been used in several clinical contexts and is thought to exert biological effects through mechanotransduction, a process in which mechanical stimuli are converted into cellular responses that activate endothelial cells, fibroblasts, and myofibroblasts, promoting vascularization, lymphatic drainage, and extracellular matrix remodelling [12–15]. Suction generates different levels of tension across the cutaneous, adipose, and muscular layers, with the skin being particularly susceptible even at moderate negative pressures (100–150 mbar) [15]. In the context of laser tattoo removal, the application of negative pressure may theoretically act as an adjunctive technique by improving local perfusion and lymphatic drainage, potentially facilitating the removal of pigment fragments and intradermal gases generated during selective photothermolysis. However, their role as adjunctive tools in tattoo removal remains poorly investigated.
The Kirby-Desai scale is widely used as a predictive tool to estimate the number of treatment sessions required for tattoo removal, incorporating variables such as anatomical location, skin phototype, pigment colour and density, number of ink layers, and the presence of scarring [16]. However, this scale was developed based on treatment outcomes from earlier Q-switched nanosecond laser systems and may therefore not fully reflect the efficiency of modern picosecond technologies and emerging adjunctive treatment approaches. Recent studies have questioned whether the Kirby–Desai scale fully reflects the performance of modern picosecond laser technologies [1, 7, 17]. New predictive models have therefore been proposed, such as the Smarrito–Pineau model, which incorporates additional variables including ink density, anatomical location, tattoo age, and tattooing technique [18]. Although promising, these models still require validation in larger and more diverse populations.
The aim of this retrospective study was to evaluate the clinical outcomes of a vacuum-assisted multimodal picosecond laser tattoo removal protocol, including treatment clearance, number of treatment sessions, safety profile, and patient satisfaction. Kirby–Desai estimated treatment sessions were additionally assessed as a historical comparative reference.
Materials and methods
This retrospective observational case series included patients treated between 2022 and 2024 at a private clinical center. The study was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. The protocol was approved by the Ethics Committee of the Escola Superior de Saúde Norte da Cruz Vermelha Portuguesa, Oliveira de Azeméis, Portugal (Approval No. 012/2024, January 31, 2024), and followed the principles of the Declaration of Helsinki. All participants provided written informed consent before each treatment session and separately authorized the use of anonymized clinical images for scientific publication.
All consecutive patients treated with the described protocol during the study period were screened for eligibility. Tattoos were included in the final analysis only if treatment had been clinically completed and standardized photographic documentation was available for retrospective evaluation. Sixteen tattoos from adult participants aged ≥ 18 years met the inclusion criteria and were included in the final analysis. Exclusion criteria included dermatologic disease affecting the treatment area, history of cutaneous malignancy, immunosuppressive therapy within the previous year, pregnancy, active infection, or a history of hypertrophic or keloid scarring. Given the retrospective design and inclusion of treatment-completer cases with standardized documentation, the possibility of selection bias cannot be excluded.
Tattoo removal was performed using a picosecond laser system (1064 nm) combined with a negative pressure device (Table 1). All procedures were performed by the same operator under standardized safety conditions.
Table 1.
Technical specifications of the devices used in the vacuum-assisted picosecond laser tattoo removal protocol (StarWalker® PQX, Fotona, Slovenia; Green VAC®, Iskra Medical, Slovenia)
| StarWalker® PQX | Green VAC® |
|---|---|
| Wavelength: 1064 nm and 532 nm | Negative pressure (H and L): 0–500 mbar |
| Maximum energy: 800 mJ | Mode: continuous/pulsed |
| Minimum pulse duration: 300 psec | Suction time: 0–60 s |
| Maximum peak power: 2.7 GW | Suction cups: 11–60 mm |
| Pulse repetition frequency: 1–10 Hz | Voltage: 230 V, 50/60 Hz |
| Maximum spot size: 12 mm | Power: 50 VA |
Each session began with infiltration of local anaesthesia using 2% lidocaine with epinephrine (1:200,000), administered 5–10 min before treatment to optimize intra and post-procedural comfort.
The treatment protocol (Fig. 1; Table 2) consisted of three sequential standardized steps and was performed by the same operator under consistent safety conditions. The first step consisted of a full-coverage application over the tattooed area with a margin of approximately 0.5 cm. The second and third steps consisted of single full-beam applications with fluence adjusted according to pigment density and distribution (Table 2). The laser beam was applied perpendicularly to the skin with minimal overlap and without additional cooling. Between laser steps, a vacuum system was applied across the tattoo in a “#” pattern, with cup size selected according to anatomical location. Before each subsequent laser step, the area was cleansed using sterile gauze moistened with 0.9% saline followed by dry sterile gauze to remove superficial coagulated blood and tissue debris and ensure optimal visualization of the tattoo.
Fig. 1.

Schematic representation of the vacuum-assisted picosecond laser tattoo removal protocol. Legend: The sequence begins with a fractional ablative pass (FracTAT®) creating dermal microchannels, followed by two collimated 1064 nm passes interspersed with suction using the Green VAC® system. Negative pressure may facilitate the elimination of intradermal gas bubbles and pigment particles, potentially influencing tissue drainage and post-treatment tissue dynamics
Table 2.
Protocol parameters for vacuum-assisted picosecond laser tattoo removal (StarWalker® PQX, Fotona, Slovenia; Green VAC®, Iskra Medical, Slovenia)
| Device | StarWalker® PQX | StarWalker® PQX | Green VAC® |
|---|---|---|---|
| Step | 1 st Step | 2nd and 3rd Step | Inter between steps |
| Laser wavelength | Nd: YAG (1064 nm) | Nd: YAG (1064 nm) | – |
| Handpiece | Black F9 | Black | – |
| Mode | PICO FracTAT | PICO Full-beam | Pulsed |
| Spot size | 9 × 9 mm (81 microchannels, 0.2 mm) | 4 mm | Suction cup: 11–25 mm |
| Fluence | 7 mJ/px | 1–4.2 J/cm² | Pressure: 150 mbar (H)/70 mbar (L) |
| Frequency | 2 Hz | 2 Hz | Cycle time: 3–5 s |
| Pass | 1 pass, 3 stacks | 1 pass | 1 pass |
| Endpoint | Pinpoint bleeding | Frosting | None |
After each session, a standardized post-procedure regimen was applied. Betamethasone 0.5 mg/g combined with gentamicin 1 mg/g was applied immediately after treatment, followed by fusidic acid 2% for five days. A thin layer of healing cream was applied, and the area was covered with a dressing for the first three days. On day four, the dressing was removed and replaced with healing cream combined with SPF 50 + photoprotection.
Before treatment, each tattoo was evaluated using the Kirby–Desai scale [16], which was used as a historical comparative reference rather than a predictive endpoint (Table 3).
Table 3.
Sample characteristics and session estimates according to the Kirby-Desai scale and independent evaluators
| Case | Location | Fitzpatrick skin type score | Amount of ink score | Ink layering score | Scarring & tissue changes | Tattoo color score | Kirby-Desai estimated sessions | Mean sessions estimated by observers | Actual number of sessions | Patient satisfaction |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 3 | 3 | 0 | 1 | 1 | 9 | 5.50 | 3 | 5 |
| 2 | 2 | 2 | 2 | 0 | 1 | 1 | 8 | 5.67 | 3 | 5 |
| 3 | 3 | 2 | 2 | 0 | 1 | 1 | 9 | 6.50 | 4 | 5 |
| 4 | 5 | 2 | 2 | 0 | 1 | 1 | 11 | 8.33 | 3 | 5 |
| 5 | 5 | 2 | 2 | 0 | 1 | 1 | 11 | 8.33 | 3 | 5 |
| 6 | 2 | 4 | 2 | 0 | 0 | 1 | 9 | 6.00 | 4 | 5 |
| 7 | 5 | 3 | 3 | 0 | 1 | 1 | 13 | 8.17 | 3 | 5 |
| 8 | 3 | 3 | 2 | 2 | 5 | 1 | 16 | 5.50 | 4 | 4 |
| 9 | 2 | 4 | 2 | 0 | 1 | 1 | 10 | 6.67 | 4 | 5 |
| 10 | 4 | 3 | 2 | 0 | 3 | 1 | 13 | 7.33 | 4 | 5 |
| 11 | 2 | 3 | 2 | 0 | 1 | 1 | 9 | 4.17 | 3 | 5 |
| 12 | 1 | 3 | 2 | 2 | 0 | 4 | 12 | 5.33 | 2 | 5 |
| 13 | 1 | 4 | 2 | 2 | 5 | 4 | 18 | 4.17 | 2 | 4 |
| 14 | 5 | 3 | 2 | 0 | 0 | 1 | 11 | 4.50 | 3 | 5 |
| 15 | 4 | 3 | 2 | 0 | 3 | 1 | 13 | 3.33 | 3 | 5 |
| 16 | 1 | 3 | 3 | 0 | 3 | 1 | 11 | 1.83 | 3 | 5 |
| 11.44 ± 2.71 | 5.71 ± 1.85 | 3.19 ± 0.66 | Mdn = 5; IQR = 0 |
Values are presented as mean ± SD, median (Mdn), and interquartile range (IQR)
Standardized digital images were obtained using the LifeViz™ Infinity system (Quantificare S.A., France) before each session at the same anatomical location and stored for subsequent analysis. All images were captured under standardized conditions including fixed camera distance, controlled lighting, and consistent patient positioning to minimize photographic variability. Once optimal pigment clearance was achieved, images were processed using the system software.
Treatment-related adverse effects, including pigmentary alterations and textural changes, were clinically evaluated by the principal investigator throughout follow-up.
Three independent experts—(i) a medical device researcher with more than 40 years of experience, (ii) an aesthetic laser therapist, and (iii) a physician specializing in aesthetic medicine and anaesthesiology with more than 10 years of experience—blinded to treatment parameters and number of sessions, evaluated paired pre- and post-treatment photographs using a structured questionnaire without access to clinical or technical data. For each image pair, evaluators assessed pigment density, perceived cutaneous changes, estimated number of treatment sessions, estimated time interval (months) between images, and overall treatment outcome.
Pain during laser treatment was assessed immediately after each session using a 5-point numeric rating scale (NRS), where 1 represented no pain and 5 represented severe pain. Overall patient satisfaction was assessed using a 5-point Likert scale ranging from 1 (very dissatisfied) to 5 (very satisfied).
All data were entered into a password-protected Microsoft Excel database accessible only to the research team and analysed using IBM SPSS Statistics version 29.
Statistical Analysis
Treatment efficacy was assessed by comparing pigment density before and after treatment using the Wilcoxon signed-rank test, with Bonferroni correction applied when multiple comparisons were performed. Efficacy was also expressed as percentage pigment reduction calculated as: Δ% = [(Initial − Final)/Initial] × 100. Reduction was categorized as low (< 50%), moderate (50–79.9%), or high (≥ 80%).
The observed number of treatment sessions was compared with session estimates derived from the Kirby–Desai scale, used as a historical comparative reference, and with the estimates provided by the blinded independent evaluators. Differences between estimated and observed session numbers were analysed using the Wilcoxon signed-rank test.
Interobserver reliability was assessed using intraclass correlation coefficients (ICC) based on a two-way random effects model with absolute agreement [19].
Agreement between evaluators for categorical variables was assessed using Cohen’s kappa coefficient, whereas ordinal variables were analysed using Kendall’s coefficient of concordance (Kendall’s W). Adverse effects including hypopigmentation, hyperpigmentation, and scarring were descriptively analyzed based on clinical and imaging assessments. A p-value < 0.05 was considered statistically significant.
Results
Sample Characteristics
Sixteen participants were included, of whom 14 (87.5%) were female and 2 (12.5%) male. Mean participant age was 39.5 ± 11.5 years (range: 23–70 years), and mean tattoo age was 18.4 ± 9.6 years (range: 3–35 years).
Regarding skin phototype (Fitzpatrick scale), 4 participants (25%) were type II, 10 (62.5%) type III, and 2 (12.5%) type IV. Tattoo anatomical distribution included 4 (25%) on the head/neck, 4 (25%) on the upper trunk (including shoulders), 2 (12.5%) on the lower trunk, 2 (12.5%) on the arm, and 4 (25%) on distal extremities. Fourteen tattoos (87.5%) were black, whereas 2 (12.5%) corresponded to tattoo makeup. Three tattoos (18.8%) had been retattooed.
Clinical outcomes
The mean pigment reduction assessed by the investigator was 93.8 ± 12.3% (range: 50–100%). Based on the predefined efficacy categories, 93.8% of tattoos (n = 15) were classified as high efficacy (≥ 80% pigment reduction), while 6.3% (n = 1) were classified as moderate efficacy (50–79.9%) (median = 3; IQR = 0).
The mean pigment reduction estimated by the three independent evaluators was 90.3 ± 10.9% (range: 61.1–100%), with 81.3% of cases (n = 13) classified as high efficacy and 18.8% (n = 3) as moderate efficacy (Table 4).
Table 4.
Percentage pigment reduction and efficacy classification of the protocol according to the principal investigator (PI) and three independent observers (O1–O3)
| Evaluator | n | Mean (%) | SD | Min | Max | High efficacy (≥ 80%) | Moderate efficacy (50–79.9%) | Mdn | IQR |
|---|---|---|---|---|---|---|---|---|---|
| PI | 16 | 93.79 | 12.28 | 50 | 100 | 15 (93.8%) | 1 (6.3%) | 3 | 0 |
| O1 | 16 | 90.14 | 13.28 | 60 | 100 | 12 (75.0%) | 4 (25.0%) | 3 | 0.75 |
| O2 | 16 | 88.48 | 9.64 | 66.67 | 100 | 13 (81.3%) | 3 (18.8%) | 3 | 0 |
| O3 | 16 | 91.40 | 11.49 | 60 | 100 | 14 (87.5%) | 2 (12.5%) | 3 | 0 |
| Mean of observers (O1–O3) | 16 | 90.26 | 10.85 | 61.11 | 100 | 13 (81.3%) | 3 (18.8%) | 3 | 0 |
Values are presented as mean ± SD, median (Mdn), and interquartile range (IQR)
Wilcoxon signed-rank tests demonstrated statistically significant differences between pre- and post-treatment pigment assessments for all raters, including the investigator (Z ≤ − 3.55; p < 0.001) (Table 7).
Table 7.
Wilcoxon test results for efficacy and efficiency of vacuum-assisted picosecond laser tattoo removal protocol
| Variable | Evaluator/Comparison | n | Z | p |
|---|---|---|---|---|
| Perceived ink amount (Pre–Post) | O1 | 16 | –3.542 | < 0.001 |
| O2 | 16 | –3.539 | < 0.001 | |
| O3 | 16 | –3.533 | < 0.001 | |
| % Ink clearance (Pre–Post) | O1 | 16 | –3.543 | < 0.001 |
| O2 | 16 | –3.520 | < 0.001 | |
| O3 | 16 | –3.527 | < 0.001 | |
| PI | 16 | –3.551 | < 0.001 | |
| Estimated vs. actual number of sessions | O1 vs. Actual | 16 | –3.444 | < 0.001 |
| O2 vs. Actual | 16 | –2.940 | 0.003 | |
| O3 vs. Actual | 16 | –3.345 | < 0.001 | |
| Mean observers vs. Actual | 16 | –3.390 | < 0.001 | |
| Kirby-Desai vs. Actual | 16 | –3.537 | < 0.001 | |
| Estimated vs. actual time between images | O1 vs. Actual | 16 | –0.57 | 0.955 |
| O2 vs. Actual | 16 | –1.918 | 0.055 | |
| O3 vs. Actual | 16 | –2.592 | 0.010 | |
| Mean observers vs. Actual | 16 | –1.733 | 0.083 |
PI principal investigator; O1–O3 = independent observers
Interobserver reliability was high (ICC = 0.854; 95% CI: 0.685–0.941; p < 0.001), indicating strong agreement between evaluators (Table 5). Agreement between blinded evaluators for ordinal outcome variables ranged from moderate to substantial, as shown in Table 6.
Table 5.
Interobserver absolute agreement (intraclass correlation coefficient, ICC) for interval variables
| Variable | Evaluators | n | ICC | 95% CI | p |
|---|---|---|---|---|---|
| Percentage pigment reduction | PI, O1, O2, O3 | 16 | 0.854 | 0.685–0.941 | < 0.001 |
| Estimated number of sessions | O1, O2, O3 | 16 | 0.853 | 0.649–0.941 | < 0.001 |
| Estimated time between images | O1, O2, O3 | 16 | 0.876 | 0.335–0.924 | < 0.001 |
| % ink pre-treatment | PI, O1, O2, O3 | 16 | 0.838 | 0.116–0.843 | < 0.001 |
| % ink post-treatment | PI, O1, O2, O3 | 16 | 0.821 | 0.611–0.927 | < 0.001 |
PI principal investigator; O1–O3 = independent observers
Table 6.
Interobserver agreement using Kendall’s W test for ordinal variables
| Variable | Evaluators | n | Kendall’s W | p |
|---|---|---|---|---|
| Amount of ink (pre-treatment) | O1, O2, O3 | 16 | 0.583 | < 0.001 |
| Amount of ink (post-treatment) | O1, O2, O3 | 16 | 0.269 | 0.014 |
| Overall outcome classification | O1, O2, O3 | 16 | 0.619 | < 0.001 |
O1–O3 = independent observers
The mean number of sessions performed was 3.19 ± 0.66 (range: 2–4 sessions). For historical comparative purposes, Kirby–Desai estimated sessions were additionally calculated, yielding a mean estimate of 11.44 ± 2.71 sessions (range: 8–18 sessions). Independent evaluator estimates demonstrated a mean of 5.71 ± 1.85 sessions (range: 1.83–8.33 sessions). The observed number of treatment sessions was significantly lower than both evaluator estimates and Kirby–Desai estimated values (Wilcoxon Z = − 3.390 and − 3.537, respectively; p < 0.001) (Tables 3 and 7).
Kirby–Desai estimates consistently exceeded the observed number of treatment sessions and the percent error analysis demonstrated a tendency toward overestimation: 83.33 ± 70.47% (range: −16.67 to 233.33%) for observer 1 (O1), 70.31 ± 74.04% (range: −66.67 to 233.33%) for observer 2 (O2), 96.88 ± 71.35% (range: −33.33 to 250%) for observer 3 (O3), and 282.81 ± 167.15% (range: 125–700%) for the Kirby-Desai scale (Table 8).
Table 8.
Percent error of session estimates and differences between estimated and actual treatment duration
| Variable | Comparison | n | Mean | SD | Min | Max |
|---|---|---|---|---|---|---|
| Percent error of the number of sessions | Actual vs. Observer 1 | 16 | 83.33 | 70.47 | –16.67 | 233.33 |
| Actual vs. Observer 2 | 16 | 70.31 | 74.04 | –66.67 | 233.33 | |
| Actual vs. Observer 3 | 16 | 96.88 | 71.35 | –33.33 | 250.00 | |
| Actual vs. Kirby-Desai scale | 16 | 282.81 | 167.15 | 125.00 | 800.00 | |
| Actual vs. Mean of observers (O1–O3) | 16 | 83.51 | 63.51 | –38.89 | 177.78 | |
| Difference in months (estimated vs. actual) | Observer 1 | 16 | 0.06 | 6.70 | –11 | 12 |
| Observer 2 | 16 | –5.50 | 9.79 | –26 | 12 | |
| Observer 3 | 16 | –7.00 | 8.34 | –20 | 6 | |
| Mean of observers (O1–O3) | 16 | –4.15 | 7.85 | –19 | 10 |
O1–O3 = independent observers
Interobserver reliability for estimated treatment sessions was also high (ICC = 0.853; 95% CI: 0.649–0.941; p < 0.001).
Cutaneous Changes and Safety
McNemar’s test showed no statistically significant differences in the occurrence of hypopigmentation (p = 0.25–1.00), hyperpigmentation (p = 0.031–1.00; not significant after Bonferroni correction), or scarring (p = 1.00).
Interobserver agreement for hypopigmentation was substantial to almost perfect (κ = 0.765–1.000; p < 0.01). For hyperpigmentation and scarring, low variability limited statistical testing, although descriptive agreement between evaluators was observed (Tables 9 and 10).
Table 9.
Cutaneous changes before and after treatment, assessed by McNemar’s test
| Variable | Evaluator | n | Pre-treatment cases | Post-treatment cases | Pre–Post difference | McNemar’s test p |
|---|---|---|---|---|---|---|
| Identification of change | O1 | 16 | 2 | 5 | –3 | 0.453 |
| O2 | 16 | 1 | 3 | –2 | 0.625 | |
| O3 | 16 | 1 | 8 | –7 | 0.039 | |
| Hypopigmentation | O1 | 16 | 0 | 2 | 2 | 0.500 |
| O2 | 16 | 0 | 3 | –3 | 0.250 | |
| O3 | 16 | 0 | 2 | –2 | 0.500 | |
| PI | 16 | 3 | 3 | 0 | 1.000 | |
| Hyperpigmentation | O1 | 16 | 2 | 3 | –1 | 1.000 |
| O2 | 16 | – | – | – | – | |
| O3 | 16 | 0 | 6 | 6 | 0.031 | |
| PI | 16 | 0 | 2 | –2 | 0.500 | |
| Scarring | O1 | 16 | – | – | – | – |
| O2 | 16 | 1 | 0 | 1 | 1.000 | |
| O3 | 16 | 1 | 0 | 1 | 1.000 |
PI principal investigator; O1–O3 = independent observers
Table 10.
Interobserver agreement (Cohen’s kappa coefficient) for nominal variables of dermatologic changes
| Variable | Comparison | n | Cohen’s kappa | p |
|---|---|---|---|---|
| Hypopigmentation (Pre-treatment) | PI vs. O1 | 16 | 0.000 | – |
| PI vs. O2 | 16 | 0.000 | – | |
| PI vs. O3 | 16 | 0.000 | – | |
| O1 vs. O2 | 16 | – | – | |
| O1 vs. O3 | 16 | – | – | |
| O2 vs. O3 | 16 | – | – | |
| Hypopigmentation (Post-treatment) | PI vs. O1 | 16 | 0.294 | 0.226 |
| PI vs. O2 | 16 | 0.590 | 0.018 | |
| PI vs. O3 | 16 | 0.294 | 0.226 | |
| O1 vs. O2 | 16 | 0.765 | 0.002 | |
| O1 vs. O3 | 16 | 1.000 | < 0.001 | |
| O2 vs. O3 | 16 | 0.765 | 0.002 | |
| Hyperpigmentation (Pre-treatment) | PI vs. O1 | 16 | 0.000 | – |
| PI vs. O2 | 16 | – | – | |
| PI vs. O3 | 16 | – | – | |
| O1 vs. O2 | 16 | 0.000 | – | |
| O1 vs. O3 | 16 | 0.000 | – | |
| O2 vs. O3 | 16 | – | – | |
| Hyperpigmentation (Post-treatment) | PI vs. O1 | 16 | –0.176 | 0.468 |
| PI vs. O2 | 16 | 0.000 | – | |
| PI vs. O3 | 16 | 0.077 | 0.696 | |
| O1 vs. O2 | 16 | 0.000 | – | |
| O1 vs. O3 | 16 | 0.556 | 0.013 | |
| O2 vs. O3 | 16 | 0.000 | – | |
| Scarring (Pre-treatment) | O1 vs. O2 | 16 | 0.000 | – |
| O1 vs. O3 | 16 | 0.000 | – | |
| O2 vs. O3 | 16 | –0.067 | 0.790 | |
| Scarring (Post-treatment) | O1 vs. O2 | 16 | – | – |
| O1 vs. O3 | 16 | – | – | |
| O2 vs. O3 | 16 | – | – |
PI principal investigator; O1–O3 = independent observers
Additionally, 81.3% of scars identified by the investigator before treatment were no longer detected in post-treatment evaluations. Only one scar was reported by expert 2 in pre-treatment images, whereas none were identified after treatment (Fig. 2).
Fig. 2.

Three-dimensional skin surface analysis with the Quantificare® LifeViz™ system. Legend: Comparison between pre-treatment (A) and post-treatment (B) images of a tattoo located on the forearm. The false-colour scale (0.000 to –1.000 mm) represents skin depressions, with reduced irregularities after the protocol, suggesting improvement in tissue quality
Pain and patient satisfaction
During laser treatment, 8 participants (50%) reported no pain, while the remaining 8 (50%) reported grade 2/5 on the pain scale (median = 1.5; IQR = 1).
Overall satisfaction was high: 14 participants (87.5%) reported being very satisfied and 2 (12.5%) satisfied (median = 5; IQR = 0).
Discussion
This retrospective case series demonstrated high tattoo clearance rates following a vacuum-assisted multimodal picosecond laser protocol, with more than 90% pigment clearance achieved after a mean of 3.2 treatment sessions. These outcomes were supported by excellent interobserver agreement among blinded evaluators, high patient satisfaction, and the absence of severe long-term dermatologic complications. The use of three independent blinded evaluators strengthens the methodological robustness of the study by reducing potential observer bias and improving the reliability of treatment outcome assessment.
Comparable studies in the literature report similar levels of pigment clearance but generally require a higher number of treatment sessions. Marini et al. [7], for example, reported 97% pigment clearance after an average of 4.85 sessions, corresponding to a 40% reduction compared with the number of sessions estimated based on the Kirby-Desai score. Their protocol incorporated Q-switched laser microdrilling combined with multipass full-beam treatment using a proprietary MaQx pulse modality (a burst of 500–600 micropulses delivered within a 5-ns super-pulse), rather than a true picosecond laser system, and did not include vacuum assistance. Likewise, Pedrelli et al. [17] reported complete clearance of most tattoos—excluding those containing white titanium dioxide–based pigments—after a mean of 7.7 sessions, representing a 24.8% reduction compared with Kirby-Desai predictions, also without vacuum technology.
In the present study, ≥ 90% clearance was achieved in more than 80% of cases with an average of only three sessions. For historical comparative purposes, Kirby–Desai estimated sessions were additionally calculated and demonstrated substantially higher estimated treatment numbers. However, these findings should be interpreted cautiously, since the Kirby–Desai scale was originally developed using earlier Q-switched nanosecond laser systems and may not fully reflect the performance of modern picosecond technologies and multimodal protocols. Moreover, because fractional pretreatment, multipass picosecond laser application, and vacuum assistance were combined within the same protocol, the independent contribution of vacuum assistance cannot be determined.
Laser tattoo removal is fundamentally based on the principle of selective photothermolysis, whereby short pulses of laser energy are preferentially absorbed by pigment particles, producing rapid thermal and photoacoustic fragmentation while minimizing damage to surrounding tissue structures [20]. Picosecond lasers generate stronger photomechanical effects than earlier nanosecond Q-switched systems, resulting in smaller pigment fragments that are more readily cleared through biological mechanisms [21, 22]. Earlier comparative investigations demonstrated that picosecond pulse durations produce more efficient pigment fragmentation and improved tattoo fading compared with nanosecond lasers [23].
Following laser-induced fragmentation, pigment particles are removed through immune-mediated processes. Experimental studies have shown that tattoo pigments are phagocytosed by dermal macrophages, which play a central role in pigment persistence and clearance through repeated cycles of uptake, cell death, and recapture of pigment particles [24]. Fragmented pigment may subsequently migrate through lymphatic pathways, a mechanism supported by reports of tattoo pigment deposition in regional lymph nodes [24, 25]. Recent in vivo investigations using multiphoton microscopy and optical coherence tomography have further demonstrated that fragmented tattoo particles may persist within epidermal and dermal layers for several weeks to months following picosecond laser exposure, supporting the concept that tattoo clearance represents a prolonged biological process rather than an exclusively immediate photomechanical event [11]. These findings also suggest that pigment elimination may continue between treatment sessions through transepidermal extrusion and immune-mediated clearance pathways [11].
Another noteworthy observation in this study was the favourable response of distally located tattoos, such as those on the wrists, hands, ankles, and feet. These anatomical regions are traditionally considered more challenging to treat due to reduced vascularization, slower lymphatic clearance, and increased mechanical stress, often requiring a greater number of sessions and longer intervals between treatments [17, 18, 26]. In the present study, distal tattoos frequently achieved clearance in fewer sessions than historically predicted by the Kirby–Desai scale and, in some cases, demonstrated responses comparable to those observed in proximal anatomical regions. Although interesting, these findings should be interpreted cautiously given the limited sample size and the presence of multiple confounding variables that may influence treatment response according to anatomical location.
The clinical outcomes observed in this study may potentially be related to the interaction of several complementary mechanisms. During laser exposure, rapid heating of intracellular water generates epidermal whitening or “frosting,” caused by the formation of gas vacuoles within the epidermis and superficial dermis that temporarily scatter incident laser light. This phenomenon produces transient optical scattering that can limit laser penetration during subsequent passes [10]. Previous investigations have demonstrated that fractional ablative laser pretreatment can reduce this optical shielding effect by creating microchannels in the epidermis that facilitate gas release and improve laser penetration [7].
Building upon this concept, the addition of controlled negative pressure between laser passes may theoretically further influence these mechanisms. Vacuum application may facilitate the displacement of gas byproducts, tissue debris, and fragmented pigment particles through laser-induced microchannels while simultaneously influencing local microcirculation and lymphatic drainage [15]. In addition, negative pressure may transiently modify dermal tissue dynamics, potentially facilitating displacement of fragmented pigment particles. Improved perfusion may hypothetically enhance recruitment of immune cells involved in pigment clearance, whereas mechanical deformation of tissue may stimulate mechanotransduction pathways associated with fibroblast activation and extracellular matrix remodelling [12, 27]. However, these mechanisms remain speculative and cannot be confirmed by the present study design.
Mechanotransduction refers to the conversion of mechanical stimuli into biochemical signals capable of modulating cellular behaviour and tissue remodelling. Experimental and clinical studies have demonstrated that negative pressure can stimulate fibroblast activity, promote collagen realignment, increase tissue elasticity, and induce regenerative responses within the dermis [12, 27]. These biological effects may hypothetically contribute to pigment clearance and tissue remodelling following treatment.
Interestingly, 81.3% of tattoos in the present cohort were clinically identified by the investigator as presenting pre-existing scarring prior to treatment, yet these textural abnormalities were no longer detected by independent evaluators after treatment (Figs. 3 and 4). According to Kato et al. [21], tattoo-associated scarring results from excessive collagen deposition and dermal fibrosis, which can trap pigment particles within the extracellular matrix and hinder immune-mediated pigment clearance. Marini et al. [7] also reported improvements in skin texture following fractional ablative laser treatments, attributed to dermal remodelling processes. Nevertheless, given the retrospective design and lack of objective scar quantification, definitive conclusions regarding scar remodelling cannot be established.
Fig. 3.

Tattoo removal on the fifth finger of the left hand using the vacuum-assisted picosecond laser protocol. Legend: (A–E) Baseline pre-treatment images: clinical photograph (A), 2D reconstruction (B), vascularization map (C), pigment map (D), and three-dimensional skin surface reconstruction (E). (F–J) Images after three sessions of the protocol: clinical photograph (F), 2D reconstruction (G), vascularization map (H), pigment map (I), and three-dimensional skin surface reconstruction (J). Significant pigment clearance was observed after three treatment sessions, compared with 11 sessions estimated by the Kirby–Desai scale, which is presented for historical comparison
Fig. 4.

Tattoo removal on the inner right wrist using the vacuum-assisted picosecond laser protocol. Legend: (A–E) Pre-treatment images: clinical photograph (A), 2D reconstruction (B), pigment map (C), vascularization map (D), and three-dimensional skin surface reconstruction (E). (F–J) Images after four sessions: clinical photograph (F), 2D reconstruction (G), pigment map (H), vascularization map (I), and three-dimensional reconstruction (J). Significant pigment clearance was observed after four treatment sessions, compared with 10 sessions estimated by the Kirby–Desai scale, which is presented for historical comparison
Patient satisfaction in this cohort was consistently high, with 87.5% of participants reporting being very satisfied and the remaining 12.5% reporting satisfaction with the treatment outcome. Pain levels during treatment were low (median score of 1.5 on a 5-point scale), supporting the tolerability of the protocol. In clinical practice, the financial cost and time investment associated with tattoo removal often exceed those of the original tattooing procedure itself, representing a major barrier to treatment completion. Therefore, protocols capable of reducing the number of sessions required while maintaining acceptable safety profiles are clinically desirable for both patients and practitioners [7, 28].
Combined and adjunctive approaches to laser tattoo removal represent a growing area of research. Strategies currently being explored include multipass laser protocols, the use of perfluorodecalin-infused transparent patches to reduce frosting and enable rapid repeated exposures, and adjunctive technologies such as acoustic shockwave devices designed to accelerate pigment clearance [26, 29, 30]. Within this evolving landscape, the integration of electric vacuum systems represents a potentially promising technological development. Unlike manual suction techniques, electrically controlled systems provide stable tissue positioning and reproducible negative pressure levels, potentially improving treatment consistency [31].
Nevertheless, the use of vacuum systems also raises important considerations regarding infection control. As observed in other medical fields such as dentistry, where suction devices frequently come into contact with patient fluids, negative pressure systems may present a theoretical risk of cross-contamination if appropriate hygiene protocols are not implemented [32]. Accordingly, the adoption of vacuum-assisted laser protocols should be accompanied by clearly defined disinfection procedures and adequate staff training to ensure both treatment efficacy and patient safety.
Several limitations should be acknowledged when interpreting these findings. The relatively small sample size, retrospective design, absence of a contemporaneous control group, and inclusion of only tattoos that completed treatment limit the generalizability of the results and introduce potential selection bias. In addition, because the protocol combined fractional pretreatment, multipass picosecond laser application, and vacuum assistance, the specific contribution of vacuum therapy cannot be isolated. The study also included predominantly black tattoos, limiting extrapolation to multicoloured tattoos. Furthermore, although standardized imaging and blinded expert assessment were used, no automated image-analysis software was employed for objective pigment quantification.
Future prospective, randomized, controlled studies including larger and more diverse tattoo populations are warranted to further evaluate multimodal treatment strategies and better clarify the role of adjunctive vacuum-assisted approaches in tattoo removal optimization.
Conclusion
This retrospective case series suggests that a vacuum-assisted multimodal picosecond laser tattoo removal protocol may represent an effective and well-tolerated approach, achieving high levels of pigment clearance with relatively few treatment sessions. In addition to pigment reduction, improvements in local tissue appearance and favourable responses in distal anatomical regions were observed, although these findings should be interpreted cautiously given the retrospective design and the absence of a control group.
The combination of picosecond laser technology with adjunctive mechanical approaches such as controlled negative pressure may represent a promising multimodal strategy for optimizing tattoo removal protocols. More broadly, vacuum-assisted approaches may warrant further investigation as supportive tools capable of influencing laser–tissue interaction and post-treatment tissue dynamics in dermatologic laser therapies.
However, because the protocol combined fractional pretreatment, multipass picosecond laser application, and vacuum assistance, the specific contribution of the vacuum component cannot be determined from the present study. Larger prospective controlled studies with longer follow-up are necessary to validate these findings, assess long-term outcomes, and establish standardized treatment parameters.
Author contributions
G.C. conceived and designed the study, performed the treatments, collected and analyzed the data, and wrote the main manuscript. L.M. supervised the study, contributed to data interpretation, and critically revised the manuscript. All authors reviewed and approved the final version of the manuscript. Blinded evaluation of clinical images was performed by independent external experts.
Funding
No funding was received for this study.
Data availability
The datasets generated and/or analyzed during the current study are not publicly available due to patient privacy and confidentiality restrictions but are available from the corresponding author on reasonable request, in accordance with ethical and institutional guidelines.
Declarations
Ethics approval
The study was approved by the Ethics Committee of the Escola Superior de Saúde Norte da Cruz Vermelha Portuguesa, Oliveira de Azeméis, Portugal (Approval No. 012/2024, January 31, 2024).
Consent to participate
Written informed consent was obtained from all participants included in this study.
Consent for publication
Written informed consent for publication of clinical photographs and anonymized data was obtained from all participants.
Clinical trial registration
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
The original version of this article was revised: This article was originally published with an omitted ORCID for the author Liliana Mota.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Ana Gisela Carvalho Campos, Email: enfgiselacampos@gmail.com.
Liliana Andreia Neves da Mota, Email: liliana.mota@essnortecvp.pt.
References
- 1.Egozi E, Toledano O (2024) Retrospective clinical evaluation of Q-switched Nd:YAG laser safety and efficacy in tattoo removal: a new perspective on the Kirby-Desai scale. J Cosmet Dermatol 23(3):818–823. 10.1111/jocd.16201 [DOI] [PubMed] [Google Scholar]
- 2.Altunay İK, Güngör İE, Ozkur E et al (2022) Tattoos: demographics, motivations, and regret in dermatology patients. Indian J Dermatol 67(6):834. 10.4103/ijd.ijd_879_22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Morlock R, Morlock A (2023) Think before you ink: perception, prevalence, and correlates of tattooing and tattoo regret in US adults. Cureus 15(11):e48167. 10.7759/cureus.48167 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mitwalli H, Alfurayh N (2024) Tattoo regret, complications, and removal: a cross-sectional study among tattooed individuals in Saudi Arabia. Dermatol Res Pract 2024:5673785. 10.1155/2024/5673785 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Straits Research. Tattoo removal market size, share, growth, and trends, 2023–2031. Published 2023. Accessed May 10 (2025) https://straitsresearch.com/report/tattoo-removal-market
- 6.Wellwisp (2025) What percent of people regret tattoos? Published May 12, 2023. Accessed May 10. https://wellwisp.com/what-percent-of-people-regret-tattoos/
- 7.Marini L, Marini S, Cutlan J, Hreljac I (2022) Correction to: Q S laser microdrilling and multipass full beam Q S laser for tattoo removal—a case series. Lasers Med Sci 37(3):1773. 10.1007/s10103-021-03468-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wu DC, Goldman MP, Wat H, Chan HHL (2021) A systematic review of picosecond laser in dermatology: evidence and recommendations. Lasers Surg Med 53(1):9–49. 10.1002/lsm.23244 [DOI] [PubMed] [Google Scholar]
- 9.Hardy CL, Kollipara R, Hoss E, Goldman MP (2020) Comparative evaluation of 15 laser and perfluorodecalin combinations for tattoo removal. Lasers Surg Med 52(7):583–585. 10.1002/lsm.23197 [DOI] [PubMed] [Google Scholar]
- 10.Kossida T, Rigopoulos D, Katsambas A, Anderson RR (2012) Optimal tattoo removal in a single laser session based on the method of repeated exposures. J Am Acad Dermatol 66(2):271–277. 10.1016/j.jaad.2011.07.024 [DOI] [PubMed] [Google Scholar]
- 11.Nguyen L, Mess C, Huck V, Schneider SW, Herberger K (2025) Intravital visualization of tattoo particles after picosecond laser treatment. Skin Res Technol 31(10):e70283. 10.1111/srt.70283 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Charras G, Yap AS (2018) Tensile forces and mechanotransduction at cell-cell junctions. Curr Biol 28(8):R445–R457. 10.1016/j.cub.2018.02.003 [DOI] [PubMed] [Google Scholar]
- 13.Moortgat P, Meirte J, Van Daele U, Anthonissen M, Vanhullebusch T, Maertens K (2020) Vacuum massage in the treatment of scars. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG (eds) Textbook on Scar Management: State of the Art Management and Emerging Technologies. Springer, Cham, pp 475–483 [PubMed] [Google Scholar]
- 14.Veronese S, Bacci PA, Garcia-Gimenez V, Canel Micheloud CC, Haro García NL, Sbarbati A (2024) V-EMF therapy: a new painless and completely non-invasive treatment for striae gravidarum. J Cosmet Dermatol 23(6):2007–2014. 10.1111/jocd.16220 [DOI] [PubMed] [Google Scholar]
- 15.González-Muñoz A, Navarro-Ledesma S (2025) Immediate changes in the elasticity of tissue and the pain pressure threshold in cesarean scar tissue after a vacuum intervention: an open clinical trial. Biomedicines 13(3):557. 10.3390/biomedicines13030557 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kirby W, Desai A, Desai T, Kartono F, Geeta P (2009) The Kirby-Desai scale: a proposed scale to assess tattoo-removal treatments. J Clin Aesthet Dermatol 2(3):32–37 [PMC free article] [PubMed] [Google Scholar]
- 17.Pedrelli V, Azzopardi E, Azzopardi E, Tretti Clementoni M (2020) Picosecond laser versus historical responses to Q-switched lasers for tattoo treatment. J Cosmet Laser Ther 22(4–5):210–214. 10.1080/14764172.2021.1886307 [DOI] [PubMed] [Google Scholar]
- 18.Menozzi-Smarrito C, Pineau N (2025) A new predictive model for tattoo removal: leveraging patient and tattoo characteristics. J Cosmet Dermatol 24(7):e70186. 10.1111/jocd.70186 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155–163. 10.1016/j.jcm.2016.02.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220(4596):524–527. 10.1126/science.6836297 [DOI] [PubMed] [Google Scholar]
- 21.Kato H, Doi K, Kanayama K et al (2020) Combination of dual wavelength picosecond and nanosecond pulse width neodymium-doped yttrium-aluminum-garnet lasers for tattoo removal. Lasers Surg Med 52(6):515–522. 10.1002/lsm.23181 [DOI] [PubMed] [Google Scholar]
- 22.Gurnani P, Williams N, Al-Hetheli G et al (2022) Comparing the efficacy and safety of laser treatments in tattoo removal: a systematic review. J Am Acad Dermatol 87(1):103–109. 10.1016/j.jaad.2020.07.117 [DOI] [PubMed] [Google Scholar]
- 23.Ross V, Naseef G, Lin G et al (1998) Comparison of responses of tattoos to picosecond and nanosecond Q-switched neodymium: YAG lasers. Arch Dermatol 134(2):167–171. 10.1001/archderm.134.2.167 [DOI] [PubMed] [Google Scholar]
- 24.Baranska A, Shawket A, Jouve M et al (2018) Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. J Exp Med 215(4):1115–1133. 10.1084/jem.20171608 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chikkamuniyappa S, Sjuve-Scott R, Lancaster-Weiss K, Miller A, Yeh IT (2005) Tattoo pigment in sentinel lymph nodes: a mimicker of metastatic malignant melanoma. Dermatol Online J 11(1):14 Published 2005 Mar 1 [PubMed] [Google Scholar]
- 26.Nguyen HT, Doan EVL, Tran TNA, Vu TTP, Phan HN, Sobanko JF (2021) Safety and efficacy of tattoo removal using a dual-wavelength 1064/532-nm picosecond laser in patients with Fitzpatrick skin type III and IV. Lasers Surg Med 53(7):939–945. 10.1002/lsm.23333 [DOI] [PubMed] [Google Scholar]
- 27.Laura S, Veronese S, Alberti G et al (2023) Vacuum and electromagnetic field in synergy for skin rejuvenation: a retrospective study on 217 patients. J Cosmet Dermatol 22(11):2989–2995. 10.1111/jocd.15871 [DOI] [PubMed] [Google Scholar]
- 28.Kaminer MS, Capelli CC, Sadeghpour M, Ibrahim O, Honda LL, Robertson DW (2020) Increased tattoo fading in a single laser tattoo removal session enabled by a rapid acoustic pulse device: a prospective clinical trial. Lasers Surg Med 52(1):70–76. 10.1002/lsm.23163 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Biesman BS, O’Neil MP, Costner C (2015) Rapid, high-fluence multi-pass Q-switched laser treatment of tattoos with a transparent perfluorodecalin-infused patch: a pilot study. Lasers Surg Med 47(8):613–618. 10.1002/lsm.22399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vangipuram R, Hamill SS, Friedman PM (2018) Accelerated tattoo removal with acoustic shock wave therapy in conjunction with a picosecond laser. Lasers Surg Med 50(9):890–892. 10.1002/lsm.22945 [DOI] [PubMed] [Google Scholar]
- 31.Nedelec B, Edger-Lacoursière Z, Gauthier N, Marois-Pagé E, Jean S (2024) Randomized, controlled, within-patient, single-blinded pilot study to evaluate the efficacy of 12 weeks of endermotherapy with adult burn survivors. Burns 50(9):107269. 10.1016/j.burns.2024.09.008 [DOI] [PubMed] [Google Scholar]
- 32.Lv X, Yan K, Han X et al (2024) Effective disinfecting of negative pressure pipelines of DCUs reduces the risk of cross infection in dental care. J Oral Microbiol 16(1):2299538. 10.1080/20002297.2023.2299538 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets generated and/or analyzed during the current study are not publicly available due to patient privacy and confidentiality restrictions but are available from the corresponding author on reasonable request, in accordance with ethical and institutional guidelines.
